IRIDEX (IRIX) Proxy Filing summary

Executive summary

• Stockholders are asked to approve an amendment and restatement of the certificate of incorporation to modernize the charter, last updated in 1996, and increase authorized common stock from 30,000,000 to 100,000,000 shares and preferred stock to 2,000,000 shares, including 1,000,000 Series B Preferred Stock.

• The Restated Charter clarifies rights and preferences for Series B Preferred Stock, removes certain payment and conversion provisions, and aligns consideration for Common and Series B Preferred Stock in change of control or bankruptcy events.

• The Board recommends approval, stating the changes provide flexibility for future corporate needs and strategic goals, with no immediate dilutive effect but potential future dilution if new shares are issued.

Voting matters and shareholder proposals

• Proposal Four seeks approval for the Restated Charter, requiring a majority of both common and Series B Preferred Stock voting separately.

• Abstentions and broker non-votes will count as votes against the proposal.

• The Board unanimously recommends voting in favor of the Restated Charter Proposal.

Board of directors and corporate governance

• The number of directors is set by Board resolution; vacancies and new directorships are filled by the Board, not stockholders.

• No cumulative voting for directors; directors serve until successors are elected or upon earlier resignation or removal.

• Special meetings of stockholders can only be called by the Board, chairperson, CEO, or president.

• Advance notice is required for stockholder nominations and proposals.